Helios will host a free webinar on April 21st at noon to discuss the results of its annual Drug Trends Report. The 2015 edition was released last week and aims to analyze prevailing trends affecting pharmacy claim outcomes and the impact of the company’s programs. Helios notes that industry positives reflected in its data were decreased utilization of opioids and lower morphine equivalent dose (MED) per prescription and per claim. Tron Emptage, RPh, chief clinical officer for Helios will be joined by several other Helios executives to present the information.
Read full details, register for the webinar, and download the 2015 Drug Trends report via WorkCompWire here.